TRPA1 and hepatocellular carcinoma: In HCC-44 cells (Supplementary Fig. 2d, e), IP with anti-TRPA1 pulled down a minimal amount of FGFR2 relative to HCC-515 cells, especially if normalized to the control lane (IP and IB with anti-TRPA1).